Increased expression of the gene for the Y1 receptor of neuropeptide Y in the amygdala and paraventricular nucleus of Y 1R/LacZ transgenic mice in response to restraint stress

Journal of Neurochemistry

Volumn 89, Issue 6, 2004, Pages 1471-1478

  Mele, Paolo ^a   Oberto, Alessandra ^a   Serra, Mariangela ^b,c   Pisu, Maria Giuseppina ^b,c   Floris, Ivan ^b   Biggio, Giovanni ^b,c   Eva, Carola ^a,d  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c CNR   (Italy)

^d Sezione di Farmacologia   (Italy)

Author keywords

Amygdala; Hypothalamic paraventricular nucleus; Neuroactive steroids; Restraint stress; Transgenic mice; Y1 receptor for neuropeptide Y

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; ALLOTETRAHYDRODEOXYCORTICOSTERONE; BETA GALACTOSIDASE; FINASTERIDE; LIGAND; NEUROPEPTIDE Y1 RECEPTOR; NEUROSTEROID; STEROID 5ALPHA REDUCTASE INHIBITOR; TETRAHYDRODEOXYCORTICOSTERONE; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN CORTEX; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; IMMOBILIZATION STRESS; MALE; MOUSE; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; RECEPTOR GENE; REPORTER GENE; THALAMUS MIDLINE NUCLEUS; TRANSGENIC MOUSE;

AMYGDALA; ANIMALS; CEREBRAL CORTEX; ENZYME INHIBITORS; FINASTERIDE; GENE EXPRESSION; GENES, REPORTER; LAC OPERON; MALE; MICE; MICE, TRANSGENIC; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RECEPTORS, NEUROPEPTIDE Y; RECURRENCE; RESTRAINT, PHYSICAL; STEROIDS; STRESS; TIME FACTORS;

ANIMALIA; MURINAE; MUS MUSCULUS;

EID: 3042522904     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02444.x     Document Type: Article

References (70)

1. Azzolina B., Ellsworth K., Andersson S., Geissler W., Bull, H. G. and Harris G. S. (1997) Inhibition of rat α-reductases by finasteride: evidence for isoenzyme differences in the mechanism of inhibition. J. Steroid Biochem. Mol. Biol. 61, 55-64.
2. Bannon A. W., Seda J., Carmouche M., Francis J. M., Norman M. H., Karbon B. and McCaleb M. L. (2000) Behavioral characterization of neuropeptide Y knockout mice. Brain Res. 868, 79-87.
3. A receptor function after acute stress. Neuroendocrinology 63, 166-172.
4. Barbaccia M. L., Roscetti G., Trabucchi M., Purdy R. H., Mostallino M. C., Concas A. and Biggio G. (1997) The effects of inhibitors of GABAergic transmission and stress on brain and plasma allopregnanolone concentrations. Br. J. Pharmacol. 120, 1582-1588.
5. Barbaccia M. L., Serra M., Purdy R. H. and Biggio G. (2001) Stress and neuroactive steroids. Int. Rev. Neurobiol. 46, 243-272.
6. Belelli D., Bolger M. B. and Gee K. W. (1989) Anticonvulsant profile of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Eur. J. Pharmacol. 166, 325-329.
7. Biggio G., Concas A., Corda M. G., Giorgi O., Sanna E. and Serra M. (1990) GABAergic and dopaminergic transmission in the rat cerebral cortex: effect of stress, anxiolytic and anxiogenic drugs. Pharmacol. Ther. 48, 121-142.
8. A receptor. Brain Res. 561, 157-161.
9. Blasquez C., Jegou S., Friard O., Tonon M. C., Foumier A. and Vaudry H. (1995) Effect of centrally administered neuropeptide Y on hypothalamic and hypophyseal proopiomelanocortin-derived peptides in the rat. Neuroscience 68, 221-227.
10. Britton K. T., Southerland S., Van Uden E., Kirby D., Rivier J. and Koob G. (1997) Anxiolytic activity of NPY receptor agonists in the conflict test. Psychopharmacology 132, 6-13.
11. Britton K. T., Akwa Y., Spina M. G. and Koob G. F. (2000) Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze. Peptides 21, 37-44.
12. 1-receptor-expressing neurons in the paraventricular hypothalamic nucleus of the mouse. Neuroendocrinology 70, 295-305.
13. Broqua P., Wettstein J. G., Rocher M. N., Gauthier-Martin B. and Junien J. L. (1995) Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures. Behav. Pharmacol. 6, 215-222.
14. 5 receptor subtype. Neuroendocrinology 74, 106-119.
15. Concas A., Mostallino M. C., Porcu P., Follesa P., Barbaccia M. L., Trabucchi M., Purdy R. H., Grisenti P. and Biggio G. (1998) Role of brain allopregnanolone in the plasticity of γ-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery. Proc. Natl Acad. Sci. USA 95, 13284-13289.
16. Corda M. G. and Biggio G. (1986) Stress and GABAergic transmission: biochemical and behavioural studies. Adv. Biochem. Psychopharmacol. 41, 121-136.
17. Cuccheddu T., Floros S., Serra M., Porceddu M. L., Sanna E. and Biggio G. (1995) Proconflict effect of carbon dioxide inhalation in rat. Life Sci. 56, 321-324.
18. Dallman M. F., Strack A. M., Akana S. F., Bradbury M. J., Hanson E. S., Scribner K. A. and Smith M. (1993) Feast and famine: critical role of glucocorticoids with insulin in daily energy flow. Front. Neuroendocrinol. 14, 303-347.
19. Drugan R. C., Morrow A. L., Weizman R., Weizman A., Deutsch S. I., Crawley J. N. and Paul S. M. (1989) Stress-induced behavioral depression in the rat is associated with a decrease in GABA receptor-mediated chloride ion flux and brain benzodiazepine receptor occupancy. Brain Res. 487, 45-51.
20. 1 receptor gene expression in the medial amygdaloid nucleus of transgenic mice. J. Neurochem. 79, 417-425.
21. A receptor complex during pregnancy and after delivery in the rat brain. Eur. J. Neurosci. 10, 2905-2912.
22. Franklin K. B. J. and Paxinos G. (1997) The Mouse Brain in Stereotaxic Coordinates. Academic Press, San Diego.
23. Genazzani A. R., Petraglia F., Bemardi F. et al. (1998) Circulating levels of allopregnanolone in humans: gender, age and endocrine influences. J. Clin. Endocrinol. Metab. 83, 2099-2210.
24. Grossman A., Costa A., Navarra P. and Tsagarakis S. (1993) The regulation of hypothalamic corticotropin-releasing factor release: in vitro studies. Ciba Found. Symp. 172, 129-143.
25. Gue M., Junien J. L., Reeve J. R. Jr, Rivier J., Grandt D. and Tache Y. (1996) Reversal by NPY, PYY and 3-36 molecular forms of NPY and PYY of intracisternal CRF-induced inhibition of gastric acid secretion in rats. Br. J. Pharmacol. 118, 237-242.
26. Gustafson E. L., Card J. P. and Moore R. Y. (1986) Neuropeptide Y localization in the rat amygdaloid complex. J. Comp. Neurol. 251, 349-362.
27. Haas D. A. and George S. R. (1987) Neuropeptide Y administration acutely increases hypothalamic corticotropin-releasing factor immunoreactivity: lack of effect in other rat brain regions. Life Sci. 41, 2725-2731.
28. 1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding. Reg. Peptides 41, 61-69.
29. Heilig M., Soderpalm B., Engel J. and Widerlov E. (1989) Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology 94, 524-529.
30. 1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology 8, 357-363.
31. Heilig M., Koob G. F., Elkman R. and Britton K. T. (1994) Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci. 17, 80-85.
32. Heinrichs S. C., Menzaghi F., Pich E. M., Hauger R. L. and Koob G. F. (1993) Corticotropin-releasing factor in the paraventricular nucleus modulates feeding induced by neuropeptide Y. Brain Res. 611, 18-24.
33. 1 receptor antagonist BIBP3226: antagonism with diazepam. Eur. J. Pharmacol. 317, R3-R4.
34. 1 receptor antagonist BIBP3226 in rats. Neuroreport 8, 3645-3647.
35. 1 receptor-mediated anxiolysis in the dorsocaudal lateral septum: functional antagonism of corticotropin-releasing hormone-induced anxiety. Neuroscience 104, 799-806.
36. Kask A., Harro J., von Horsten S., Redrobe J. P., Dumont Y. and Quirion R. (2002) The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci. Biobehav. Rev. 26, 259-283.
37. Kokate T. G., Svensson B. E. and Rogawski M. A. (1994) Anticonvulsant activity of neurosteroids: correlation with γ-aminobutyric acid-evoked chloride current potentiation. J. Pharmacol. Exp. Ther. 270, 1223-1229.
38. Li C., Chen P. and Smith M. S. (2000) Corticotropin releasing hormone neurons in the paraventricular nucleus are direct targets for neuropeptide Y neurons in the arcuate nucleus: an anterograde tracing study. Brain Res. 854, 122-129.
39. Liposits Z., Sievers L. and Paull W. K. (1988) Neuropeptide-Y and ACTH-immunoreactive innervation of corticotropin releasing factor (CRF)-synthesizing neurons in the hypothalamus of the rat. An immunocytochemical analysis at the light and electron microscopic levels. Histochemistry 88, 227-234.
40. Lowry O. H., Rosebrough N. J., Farr A. L. and Randall L. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-276.
41. McDonald A. J. and Pearson J. C. (1989) Coexistence of GABA and peptide immunoreactivity in non-pyramidal neurons of the basolateral amygdala. Neurosci. Lett. 100, 53-58.
42. Majewska M. D., Harrison N. L., Schwartz R. D., Barker J. L. and Paul S. M. (1986) Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232, 1004-1007.
43. Makino S., Asaba K., Nishiyama M. and Hashimoto K. (1999) Decreased type 2 corticotropin-releasing hormone receptor mRNA expression in the ventromedial hypothalamus during repeated immobilization stress. Neuroendocrinology 70, 160-167.
44. Malmstrom R. E. (2002) Pharmacology of neuropeptide Y receptor antagonists. Focus on cardiovascular functions. Eur. J. Pharmacol. 447, 11-30.
45. Michel M. C., Beck-Sickinger A., Cox H., Doods H. N., Herzog H., Larhammar D., Quirion R., Schwartz T. and Westfall T. (1998) XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev. 50, 143-150.
46. A receptor γ2 subunit enhances neuropeptide Y gene expression. Brain Res. Bull. 54, 91-99.
47. Moller C., Wiklund L., Sommer W., Thorsell A. and Heilig M. (1997) Decreased experimental anxiety and voluntary ethanol consumption in rats following central but not basolateral amygdala lesions. Brain Res. 760, 94-101.
48. 1 and Y2 receptors in neuropeptide Y-induced sensitization to sedation. J. Neurochem. 78, 1201-1207.
49. 1 receptor 5′ upstream sequence directs cell-specific and developmentally regulated LacZ expression in transgenic mice CNS. Eur. J. Neurosci. 10, 3257-3268.
50. 1 receptor gene expression in the medial amygdala of transgenic mice. Neuropharmacology 39, 227-234.
51. 1 network in the medial amygdala: a neuroanatomical basis for their functional interaction. Neuropharmacology 41, 639-642.
52. 1 receptor gene in the medial amygdala of transgenic mice during pregnancy and after delivery. J. Neurochem. 82, 1272-1281.
53. Ovesjö M. L., Gamstedt M., Collin M. and Meister B. (2001) GABAergic nature of hypothalamic leptin target neurones in the ventromedial arcuate nucleus. J. Neuroendocrinol. 13, 505-516.
54. Parker E., Van Heek M. and Stamford A. (2002) Neuropeptide Y receptors as targets for anti-obesity drug development: perspective and current status. Eur. J Pharmacol. 440, 173-187.
55. Pu S., Jain M. R., Horvath T. L., Diano S., Kalra P. S. and Kalra S. P. (1999) Interactions between neuropeptide Y and γ-aminobutyric acid in stimulation of feeding: a morphological and pharmacological analysis. Endocrinology 140, 933-940.
56. Purdy R. H., Morrow A. L., Blinn J. R. and Paul S. M. (1990) Synthesis, metabolism and pharmacological activity of 3α-hydroxy-steroids which potentiate GABA-receptor-mediated chloride ion uptake in rat cerebral cortical synaptoneurosomes. J. Med. Chem. 33, 1572-1581.
57. Purdy R. H., Morrow A. L., Moore P. H. Jr and Paul S. M. (1991) Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain. Proc. Natl. Acad. Sci. USA 88, 4553-4557.
58. Reddy D. S. (2003) Is there a physiological role for the neurosteroid THDOC in stress-sensitive conditions? Trends Pharmacol. Sci. 24, 103-106.
59. A receptor function and seizure susceptibility. J. Neurosci. 22, 3795-3805.
60. Rupprecht E., Reul J. M. H. M., Trapp T., van Steensel B., Wetzel C., Damm K., Zieglgänsberger W. and Holsboer F. (1993) progesterone receptor-mediated neuroactive steroids. Neuron 11, 523-530.
61. 1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test. Eur. J. Pharmacol. 368, 143-147.
62. A receptors in the rat brain. Eur. J. Pharmacol. 216, 457-458.
63. A receptor function in rat brain. J. Neurochem. 75, 732-740.
64. A receptor α4 subunit in association with increased anxiety. J. Neurosci. 18, 5275-5284.
65. Suda T., Tozawa F., Iwai I., Sato Y., Sumitomo T., Nakano Y., Yamada M. and Demura H. (1993) Neuropeptide Y increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus. Brain Res. Mol. Brain Res. 18, 311-315.
66. Thorsell A., Svensson P., Wiklund L., Sommer W., Ekman R. and Heilig M. (1998) Suppressed neuropeptide Y (NPY) mRNA in rat amygdala following restraint stress. Reg. Peptides 75-76, 247-254.
67. Thorsell A., Carlsson K., Ekman R. and Heilig M. (1999) Behavioral and endocrine adaptation, and upregulation of NPY expression in rat amygdala following repeated restraint stress. Neuroreport 10, 3003-3007.
68. Thorsell A., Michalkiewicz M., Dumont Y., Quirion R., Caberlotto L., Rimondini R., Mathe A. A. and Heilig M. (2000) Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc. Natl Acad. Sci. USA 97, 12852-12857.
69. Wahlestedt C., Skagerberg G., Ekman R., Heilig M., Sundler F. and Hakanson R. (1987) Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the rat. Brain Res. 417, 33-38.
70. Yamada K., Shibasaki T., Ysumori C., Imaki T., Hotta M., Wakabayashi I. and Demura H. (1996) Neuropeptide Y reverses corticotropin-releasing hormone- and psychological stress-caused shortening of sodium pentobarbital-induced sleep in rats. Brain Res. 725, 272-275.